new psychoactive substance
synthetic cathinone

How to Cite

MÉGARBANE, B. (2021). TOXICITÉ DES CATHINONES DE SYNTHÈSE : UN PROBLÈME ÉMERGEANT AUX URGENCES. Mediterranean Journal of Emergency Medicine, (23), 42-46. Retrieved from


The new psychoactive substances including synthetic cathinones have changed the landscape of recreational drugs since 2005. Mainly sold on internet, they represent a “legal” alternative to controlled and regulated psychoactive substances. The new technologies, their attractive lower prices and legal marketing contributed to make the new psychoactive substances become increasingly popular. However, significant physical, psychical, and addictive consequences of their unique or repeated use seem to represent a growing health concern with remaining uncertainties for the future. Emergency departments in the occidental countries admit increasing numbers of poisoned patents in relation to the use of synthetic cathinones, referred for excessive psychomotor stimulation and delirium. Cases of coma, seizures, cardiovascular compromise, organ failure and even fatalities have been recently reported.



Observatoire Français des Drogues et des Toxicomanie (OFDT). Nouveaux produits de synthèse et Internet. Tendances, 2013; 84.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Rapport annuel 2012 sur l’état du phénomène de la drogue en Europe. 2012. 67910db6ab4d9=qM3+JgSnf5n8x3dyNFKlP7o10JQBAAAA/Z+XAg==:1

Karila L, Megarbane B, Chevillard L, Benturquia N, Laplanche JL, Lejoyeux M. Les nouvelles susbstances psychoactives : une revue des données actuelles. Presse Med 2015; 44:383-91.

Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic Cathinones: A New Public Health Problem. Curr Neuropharmacol 2015; 13:12-20.

Spiller HA, Ryan ML, Weston RG, Jansen J. Clinical experience with and analytical confirmation of «bath salts» and «legal highs» (synthetic cathinones) in the United States. Clin Toxicol (Phila) 2011; 49:499-505.

Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, Chaboz S, Hoener MC, Liechti ME. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 2013; 168:458-70.

Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA. The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 2013; 71:130-40.

Aarde SM, Huang PK, Dickerson TJ, Taffe MA. Binge-like acquisition of 3,4 methylenedioxypyrovalerone (MDPV) self- administration and wheel activity in rats. Psychopharmacology (Berl) 2015; 232:1867-77.

Archer JR, Dargan PI, Lee HM, Hudson S, Wood DM. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clin Toxicol (Phila) 2014; 52:160-5.

Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE, et al. The European Drug Emergencies Network (Euro- DEN). Clin Toxicol (Phila) 2014; 52:239-41.